Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Management strategies in the quest for the comprehensive health care: the experience of the Specialized Pharmaceutical Services Component Authors*: Schneiders RE, Zimmermann IR, de Araujo LRM, Alexandre RF, do Nascimento Jr. JM, Gadelha CAG. Background The Brazilian public health system ensures universal, equitable and comprehensive access to health technologies, including medicines. The clinical conditions treated in the Specialized Pharmaceutical Services Component (SPSC) are defined in the Clinical Protocols and Therapeutic Guidelines (CPTD) in the form of lines of care. Objectives To describe the experience and results of the SPSC with its particular strategies in the quest for the comprehensive health care. Methods Focused on the SPSC’s issues, we did a retrospective data analysis related to its management strategies for the pharmaceutical services in the public health system in the last two years. Reduction of expenses and growth of the amount of medicines distributed 2009 2011 Substances purchased centrally by the Ministry of Health Results As a strategy to increase medicines access and optimization of resource allocation, the Ministry of Health (MoH) expanded the amount of centralized procurement medicines, from 13 to 46 products. This deed was focused on those medicines with a concentrated market. As a consequence, this action allowed average resource savings of 33% in two years, with 96% increase in the number of units distributed in the same period. Discussion The SPSC was designed in 2010 for the budgetary resources optimization and to expand access to medicines for diseases that require complex health services or high-cost medicines. Within this Component, the municipalities provide the firstline treatment and the states finance the medicines for refractory to first-line treatment. Further, the MoH finances the medicines with greatest global impact or to situations refractory to other treatments, by the centralized procurement or by financial transfers. Implications The purchasing power of the MoH, together with the appropriate selection of medicines, definition of lines of care, organization of services within the CPTD's recommendations are strategies that allowed expansion of access to medicines. *Brazilian Ministry of Health E-mail: [email protected] Ministry of Health